Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
Patents for C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815)
12/2003
12/18/2003US20030232811 Anthranilic acid derivative
12/17/2003CN1131209C Alkyl dihalogenated phenyl-substituted ketoenols useful as. pesticides and herbicides
12/16/2003US6664272 Such as 1,5-Bis-(2, 4-difluorophenyl)penta-1,4-diene-3 -one; administering to inhibit tissue factor and vascular endothelial growth factor (VEGF) production in cancerous tissue
12/16/2003US6664259 Il-8 receptor antagonists
12/11/2003WO2003101382A2 Compounds useful in the treatment of anthrax and inhibiting lethal factor
12/11/2003WO2003053347A3 Galliumcomplexes of 3-hydroxy-4-pyrones to treat mycobacterial infections
12/11/2003US20030229054 Novel amines as pharmaceutical agents
12/11/2003US20030228984 Novel substituted phenylketoenols
12/11/2003US20030228978 Catalysts containing per-ortho aryl substituted aryl or heteroaryl substituted nitrogen donors
12/10/2003EP1368334A2 Process for preparing intermediates for the manufacture of discodermolide and discodermolide analogues
12/10/2003EP1368332A1 A lactonization process
12/10/2003EP1368331A1 Continuous method for producing dihydropyrones
12/10/2003EP0970046B1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
12/10/2003EP0933346B1 NOVEL p-TERPHENYL COMPOUNDS
12/10/2003CN1130366C Substituted phenylketoenols and preparing method, midbody and their use as pestcides and herbicides
12/09/2003US6660860 Process for the selective oxidation of alcohols using readily removable nitroxyl radicals
12/09/2003US6660132 Photochemical and thermochemical solar syntheses using flat-bed solar collectors/solar reactors
12/04/2003WO2003099836A1 C-aryl glucoside sglt2 inhibitors and method
12/04/2003WO2003099769A1 Anilino liver x-receptor modulators
12/04/2003WO2003099008A1 Use of pyrone carboxylates for controlling pests
12/04/2003WO2003068825A8 Multifunctional monomers and their use in making cross-linked polymers and porous films
12/04/2003US20030225283 2-Substituted phenyl,3-polar ring,N-heroaromatic propion-amides, e.g., 1-(2-(3,4-Dichlorophenyl)-3-(tetrahydro-furan-2-yl)-propionyl)-3- methylurea; antidiabetic agents; increase the flux of glucose metabolism in beta-cells and hepatocytes
12/04/2003US20030225271 Compounds useful as reversible inhibitors of cysteine proteases
12/04/2003US20030225270 E.g., 4-acetylamino-N-(1-((4-cyano-1-methylpiperidin-4-yl-carbamoyl)-2 -(cyclohexylethyl)benzamide; Alzheimer's, auto-immune and Crohn's diseases; atherosclerosis; antiarthritic agents; osteoporosis; atherosclerosis
12/04/2003US20030225080 Treating a disorder responsive to the blockade of sodium channels
12/04/2003US20030224297 Chemically amplified resist, polymer for the chemically amplified resist, monomer for the polymer and method for transferring pattern to chemically amplified resist layer
12/04/2003CA2486644A1 Anilino liver x-receptor modulators
12/03/2003EP1366024A2 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
12/03/2003EP1366007A2 Compounds with high monoamine transporter affinity
12/03/2003EP1124813B1 Microbial transformation product
12/03/2003CN1460101A Novel compounds inhibiting factor Xa activity
12/03/2003CN1129576C Phenyl heterocyclic compound used as epoxy enzyme-2 inhibitor
12/02/2003US6656954 Such as N-hydroxy-2-(((4-phenoxyphenyl)-sulfonyl)methyl) benzamide which inhibits matrix metalloprotease activity
12/02/2003US6656328 Process for preparation of polyhydric alcohols
11/2003
11/27/2003WO2003097627A1 Method of forming iron hydroxypyrone compounds
11/27/2003WO2003097576A2 Diamino-functional chalcones
11/27/2003WO2003097575A2 Amino-functional chalcones
11/27/2003WO2003097574A2 Aminoalkoxy-functional chalcones
11/27/2003WO2003074508B1 Compounds and methods of treating cell proliferative diseases
11/27/2003WO2003014102B1 Certain substituted polyketides, pharmaceutical compositions containing them and their use in treating tumors
11/27/2003US20030220334 Bryostatins exhibit potent activity against a broad range of human cancer cell lines
11/27/2003US20030220196 Phenyl-substituted-2enamino-keto nitriles
11/27/2003US20030219880 Method for preparing (2s,3r,4s)-4-hydroxyisoleucine and analogues thereof
11/26/2003EP1363879A2 Sulfide and disulfide compounds and compositions for cholesterol management and related uses
11/26/2003EP1363876A1 Glucocorticoid receptor modulators
11/26/2003EP1363873A2 Peptide deformylase inhibitors
11/26/2003EP1363516A1 An improved process for preparing simvastatin
11/26/2003EP1119559B1 3-phenyl-pyrones
11/25/2003US6653489 Processes for producing tetrahydropyranyl-4-sulfonates and 4-aminotetrahydropyran compounds
11/25/2003US6653483 Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
11/25/2003US6653296 Antiretroviral enantiomeric nucleotide analogs
11/20/2003WO2003095441A1 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same
11/20/2003WO2003095438A1 Substituted phenylacetamides and their use as glucokinase activators
11/20/2003WO2003095421A1 Amino acid analogues
11/20/2003WO2001085664A8 Compounds and methods for regulating bacterial growth and pathogenesis
11/20/2003US20030216451 Polycyclic aryl and heteroaryl substituted 4-pyrones useful for selective inhibition of the coagulation cascade
11/20/2003US20030216434 Cyclic derivatives as modulators of chemokine receptor activity
11/20/2003US20030216383 Compounds useful as reversible inhibitors of cysteine proteases
11/20/2003US20030216260 Preparation by intramolecular cyclization
11/20/2003US20030215932 Lactonizing mevinolinic acid to lovastatin in a totally aqueous medium
11/19/2003EP1362839A2 Liquid crystal composition having a delta-epsilon- of not less than zero and liquid crystal display device
11/19/2003EP0973392B1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds
11/18/2003US6649775 Process of lactonization in the preparation of statins
11/18/2003US6649656 Anticarcinogenic, antiallergen, antishock, and antiasthmatic agents
11/18/2003US6649227 Difluorovinyl compound, liquid crystal composition and liquid crystal display
11/13/2003WO2003093286A1 Disaccharides for drug discovery
11/13/2003WO2003093208A1 Homogenous process for the hydrogenation of carboxylic acids and derivatives thereof
11/13/2003WO2003092670A1 Bombesin antagonists
11/13/2003WO2003051830A3 Enantiopure 4-deoxypentenosides, dihydropyrans and tetrahydropyrans and syntheses thereof
11/13/2003WO2003029200A3 Compounds useful as reversible inhibitors of cysteine proteases
11/13/2003WO2002098849A3 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer’s disease and similar diseases
11/13/2003WO2001040188A8 Curcumin analogues for treating cancer
11/13/2003US20030212049 Antiarthritic agents; osteoporosis; sepsis; antiulcer agents; Crohn's disease
11/13/2003CA2484582A1 Bombesin antagonists
11/12/2003EP1181286B1 3-(arylsulfonylamino)-tetrahydropyran-3-carboxylic acid hydroxamides
11/12/2003CN1127494C Neuaminic acid dervatives, their preparation and their medical use
11/06/2003WO2003091247A2 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
11/06/2003WO2003091202A1 Diketohydrazine derivative compounds and drugs contaiing the compounds as the active ingredient
11/06/2003WO2003091189A1 Cannabinoids
11/06/2003WO2003068183A8 Sunscreen compositions as well as dihydropyridines and dihydropyranes
11/06/2003CA2483314A1 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
11/06/2003CA2483072A1 Cannabinoids
11/05/2003EP1358183A2 Cysteine protease inhibitors
11/05/2003EP1358144A1 Epothilone synthesis components iii and iv: asymmetrically substituted acyloins and acyloin derivatives, method for the production thereof and method for the production of epithilone b, d and epothilone derivatives
11/05/2003EP1140058B1 N-formyl hydroxylamine derivatives as antibacterial agents
11/05/2003EP0975617B1 Inhibitors of cholesterol esterase
11/05/2003CN1454206A 2-enamino-cetonitriles substitues par phenyle
11/05/2003CN1126752C Neuraminic acid compounds
11/04/2003US6642395 Esterifying mandelic acid derivative; protecting hydroxyl group and reducing ester; sulfonating and epoxidizing
11/04/2003US6642255 Substituted carbocyclic or heterocyclic hydroxamic acid derivatives, e.g., (3R,4S)-N-hydroxy-1-methyl-3-(((4-((2-methyl-4 -quinolinyl)methoxylphenyl)sulfonyl)methyl)-4-piperidinecarboxamide
11/04/2003US6642222 Pyrano, piperidino, and thiopyrano compounds and methods of use
10/2003
10/30/2003WO2003089396A1 Direct, enantioselective aldol coupling of aldehydes using chiral organic catalysts
10/30/2003WO2003048148A3 Statin-like compounds
10/30/2003US20030203900 An inhibitors against Cathepsin enzyme, 4-oxo-tetrahydrofuran-3s-ylcarbamoyl derivatives, for treating degenerative diseases
10/30/2003US20030203234 Comprises 4-(dicyanomethylene)-2,3-dihydro-2,2-dimethyl-6-(juloidyl-9-enyl)-4H-pyran; light emitting diodes; thin film transistors
10/29/2003EP1357109A2 Process for aryl alkyl sulfide
10/29/2003EP1355872A2 Process for stereoselective synthesis of prostacyclin derivatives
10/29/2003EP1355648A2 1,2-DISUBSTITUTED CYCLIC INHIBITORS OF MATRIX METALLORPROTEASES AND TNF-$g(a)
10/29/2003EP1089964B1 Hydrazine derivatives
10/28/2003US6639084 Chemically amplified resist, polymer for the chemically amplified resist, monomer for the polymer and method for transferring pattern to chemically amplified resist layer
1 ... 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 ... 129